Respond.io Raises $62.5M Series B to Scale AI-Powered Customer Conversations Into North America and Europe
16.6.2026 10:00:00 CEST | Business Wire | Press Release
Respond.io, a customer conversation management platform, today announced a $62.5 million Series B round led by Camber Partners, with participation from Endeavor Catalyst and existing investors.
What respond.io does
Respond.io enables mid-market B2C businesses to grow revenue from high volumes of customer chats and calls. It unifies WhatsApp, Instagram, TikTok, Messenger, LINE, Telegram, WeChat, voice calls, email, web chat and 16 more integrations into a single platform with AI agents, automation, and CRMs. This turns fragmented customer conversations into a measurable revenue engine, purpose-built for real-world scale and complexity.
The company serves industries where customers initiate conversations before buying, booking, or committing, including education, healthcare, automotive, retail and travel. The platform powers 2 billion messages per quarter for more than 10,000 businesses in over 180 countries, including Toyota, British Airways, Radisson, Hertz, and Decathlon.
Respond.io generates $35M in annual recurring revenue, growing 169% year-over-year, at a 30% profit margin. It is ISO 27001 certified, GDPR compliant, and an official Meta Business and TikTok Marketing Partner.
Why Camber Partners
The funding was led by Camber Partners, a New York City-based growth equity firm that invests in only a handful of capital-efficient software businesses per year, with a pre-fund portfolio that includes Dropbox, PandaDoc, and Pipedrive. Camber brings deep operational engagement to their partnerships, including support in go-to-market, data science, and talent. As a US-based firm with European market experience, the relationship maps directly to respond.io's geographic expansion plans.
"When we started talking to Camber Partners, that conversation felt different," said Gerardo Salandra, CEO and co-founder of respond.io. "We built respond.io over nine years across markets most competitors never entered and did it profitably. Camber Partners and other investors backed us because they understand what that means: real product-market fit, with great unit economics, and a business that raises to accelerate, not to survive."
"Respond.io spent nine years building the infrastructure for high consideration, AI-native customer conversations - and they did it profitably in diverse markets. They have an exceptional team that has leveraged AI to accelerate rapidly. We believe respond.io is positioned to lead this category at a global scale," said Scott Irwin, founder and partner, Camber Partners.
From omnichannel inbox to native AI infrastructure
Respond.io launched in 2017 to solve a straightforward problem: customers were moving to messaging apps, but businesses struggled to respond from separate channel inboxes. The founding team built a platform that consolidated fragmented conversations into a single platform with automation and routing.
As frontier LLMs matured, the team realized this foundation was exactly what autonomous agents needed to operate on to enable rapid revenue acceleration for the high-consideration businesses they serve. Respond.io had spent years assembling the infrastructure — every major messaging channel, voice, email, CRM integrations, compliance controls — and accumulating the kind of operational depth that comes only from years of running high-volume conversations. This enabled it to roll out native AI technologies that meaningfully address real business needs.
This advantage is structural and compounds over time. Processing more conversations than any comparable platform creates a data flywheel — aggregate intelligence about how businesses actually deploy AI in high-volume messaging, the patterns that work, the edge cases that don't — that continuously shapes how respond.io's AI features are built and improved. Newer or lighter platforms building on the same frontier models cannot buy these operational signals or guarantee the same 99.999% uptime at the volumes AI brings. Today, Respond.io’s AI Agents engage thousands of leads daily, qualify them and close B2C sales autonomously, handing off to human operators with full context for edge cases.
The speed of respond.io’s innovation attracted some of the largest partners in the ecosystem. Meta and TikTok chose respond.io for early rollouts of WhatsApp Business Calling API, TikTok Business Messaging, and TikTok Messaging Ads — making it one of the few platforms offering end-to-end integrations for both messaging and calling.
"Most businesses still treat customer conversations as a cost to manage. The ones winning right now treat them as the revenue channel they actually are, and they're automating everything that doesn't require a human so the humans can focus where they add the most value,” Salandra said. “We see it in our customers every day — we have case studies showing AI Agents are handling 600% more leads with conversation rates as high as 84%.”
Entering North America and Europe
Respond.io built category leadership across APAC, LATAM and EMEA — markets where mobile messaging is the primary commercial channel — and reached profitability doing so. The capital from this new round will accelerate the company’s expansion in North America and Europe, where social commerce on TikTok, Instagram, and WhatsApp is growing, and mid-market B2C businesses are increasingly running the same types of revenue-critical conversations that respond.io has powered for years.
"The customer conversation management space is at an inflection point," Salandra said. "North America and Western Europe are moving toward leveraging conversations as a competitive advantage to generate revenue, using similar workflows we've already built and tested in markets where this shift happened first. We know how to serve these businesses, and with this funding, we now have the resources to reach them faster."
Reid Hoffman, co-founder of LinkedIn and Chairman of Endeavor Catalyst commented: "We are thrilled to be investing in respond.io in this new round. Respond.io is exactly the kind of company we are proud to support — founders building profitable infrastructure in emerging markets and scaling them into the world's largest economies. So proud to have them in the Endeavor Catalyst family!"
About respond.io
Respond.io is a customer conversation management platform that unifies messaging, calls, email, and CRM to help mid-market B2C businesses drive revenue from customer conversations. The platform powers 2 billion messages per quarter for 10,000+ businesses in over 180 countries and territories with 99.999% platform uptime. Respond.io is ISO 27001 certified, GDPR compliant, and an official Meta Business and TikTok Marketing partner. Founded in 2017 and headquartered in Kuala Lumpur, Malaysia, it raised US$7 million in Series A funding in 2022. For more information, visit https://respond.io.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260616926452/en/
Contacts
respond.io -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Frespond.io&eshe
et=54553895&newsitemid=20260616926452&lan=en-US&anchor=respond.io&index=6&md5=84
21b96452a651a286801c5b587c74d6
pr@respond.io
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 20263.10.2026 16:50:00 CEST | Press Release
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at the 2026 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in Montréal, Canada. Among patients evaluable for efficacy, three-year overall survival was 48% (n=35), unchanged from the two-year estimate, suggesting durable clinical benefit in this population. Responses and long-term survival were observed in both platinum-sensitive and platinum-resistant or refractory disease. At the last follow-up, 25% of patients who received at least one dose of treatment (11 of 44) were alive
emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer2.10.2026 17:12:00 CEST | Press Release
emnify, a global leader in IoT connectivity, today announced the appointments of Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001902751/en/ emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer The appointments follow the recent naming of Kenneth De Spiegeleire as Chief Executive Officer and Frank Stoecker as Executive Chairman of the Board. Together, these leadership changes strengthen emnify financial, operational, and commercial capabilities as the company enters its next phase of international growth. “We have proven momentum. Our ambition is to now turn it into global category leadership,” said Kenneth De Spiegeleire, CEO of emnify. “That requires sharper focus, disciplined execution, and the right capabilities in the right seats. Sacha brings financial lead
Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 15:00:00 CEST | Press Release
Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme
EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 15:00:00 CEST | Press Release
European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea
ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 14:00:00 CEST | Press Release
ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom